SyB L-0501RI

· SymBio Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SyB L-0501RI, covering 2023-11-24 to 2023-11-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of SyB L-0501RI in Combination With Rituximab to Treat Lymphoma [Phase 1, Phase 2]